← Back to Intel
Insider ActivityTPST
Angel Matthew, CEO and President at Tempest Therapeutics, Inc., bought $500K of TPST
Updated Jun 13, 2026
Angel Matthew
CEO and President
Tempest Therapeutics, Inc. ·
$TPST
Transaction Details
| Insider | Angel Matthew |
|---|---|
| Title | CEO and President |
| Company | Tempest Therapeutics, Inc. |
| Ticker | TPST |
| Transaction Type | Purchase |
| Transaction Date | 2026-03-24 |
| Shares Traded | 231,482 |
| Price Per Share | $2.16 |
| Total Value | $500K |
| Filed Date | 2026-03-25 |
| Accession Number | 0001931356-26-000011 |
Ownership Context
| Shares Owned After Transaction | 231,482 |
|---|---|
| Ownership Type | Indirect |
SEC Filing
Accession: 0001931356-26-000011
Other Insider Trades — TPST
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Richey William Drake | Insider | traded | — | 2026-06-04 |
| Trojanowski Justin | Corporate Controller | traded | — | 2026-03-31 |
| Maestas Nicholas | Chief Financial Officer | traded | — | 2026-03-31 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TPST — Tempest Therapeutics, Inc. →
Track TPST insider activity in real time on The Wire →
Get alerts when Angel Matthew files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 13, 2026 at 07:20 UTC